Trump's executive order lacks specifics and raises questions on what can be accomplished, what will be challenged in court.

The White House unveiled a sweeping plan to try to lower prescription drug prices, one that calls for a "most-favored nation" ...

The emergence of Haemanthus, a company formed by Elizabeth Holmes’ partner, Billy Evans, triggered a mix of shock, anger, and ...

OpenAI on Monday released a large dataset for evaluating how well large language models answer questions related to health ...

President Trump unveiled his plan to dramatically overhaul the way the U.S. pays for drugs. Pharma investors didn't seem to ...

In this week's Health Care Inc. newsletter, UnitedHealth’s financial miscues, an $800 million revenue cycle bonanza, and much ...

After his job was cut, a CDC scientist volunteered to help Milwaukee respond to the lead crisis in its public schools. For ...

Chinese and Chinese-American researchers are reassessing their futures in the U.S., potentially shifting the balance in ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

President Trump said he would sign an executive order to base U.S. drug prices on what other countries pay — usually far less ...

House Republicans have unveiled their plan to reshape Medicaid, looking for cost savings as a way to offset planned tax cuts.

President Trump confirmed late yesterday that he would revive a “most-favored nation” drug pricing policy, aiming to tie U.S.